Shepherd Financial Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$438K Hold
3,143
0.04% 167
2025
Q4
$386K Sell
3,143
-2
-0.1% -$243 0.04% 182
2025
Q3
$349K Buy
3,145
+28
+0.9% +$3.18K 0.03% 189
2025
Q2
$346K Buy
3,117
+15
+0.5% +$1.6K 0.04% 186
2025
Q1
$348K Hold
3,102
0.04% 173
2024
Q4
$287K Buy
3,102
+34
+1% +$3.06K 0.03% 185
2024
Q3
$257K Hold
3,068
0.03% 193
2024
Q2
$210K Sell
3,068
-63
-2% -$4.2K 0.03% 204
2024
Q1
$229K Buy
3,131
+63
+2% +$4.84K 0.03% 199
2023
Q4
$249K Sell
3,068
-13
-0.4% -$1.01K 0.04% 190
2023
Q3
$231K Buy
3,081
+383
+14% +$29.5K 0.04% 178
2023
Q2
$208K Buy
2,698
+68
+3% +$5.42K 0.03% 180
2023
Q1
$218K Hold
2,630
0.04% 172
2022
Q4
$226K Buy
+2,630
New +$208K 0.04% 160
2020
Q4
Sell
-3,429
Closed -$217K 133
2020
Q3
$217K Hold
3,429
0.05% 125
2020
Q2
$264K Sell
3,429
-1
-0% -$77 0.07% 112
2020
Q1
$257K Buy
+3,430
New +$237K 0.09% 106
2017
Q2
Sell
-5,171
Closed -$343K 109
2017
Q1
$343K Sell
5,171
-861
-14% -$60.5K 0.09% 91
2016
Q4
$447K Buy
+6,032
New +$448K 0.13% 81

Other funds holding GILD

Shepherd Financial Partners's GILD Position: Q1 2026 in Review

Shepherd Financial Partners held its Gilead Sciences (GILD) position steady in Q1 2026 at 3,143 shares worth $438K. The position accounts for 0.04% of the portfolio, ranked #167.

Shepherd Financial Partners first reported a position in GILD in Q4 2016 and has held it in 19 quarters since. The position peaked at $447K in Q4 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Shepherd Financial Partners held 3,143 shares of Gilead Sciences worth $438K as of Q1 2026.
  • Shepherd Financial Partners left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.04% of Shepherd Financial Partners's portfolio in Q1 2026, its #167 holding.
  • Shepherd Financial Partners first reported a position in Gilead Sciences in Q4 2016 and has held it in 19 quarters since.
  • Shepherd Financial Partners's Gilead Sciences position peaked at $447K in Q4 2016.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Shepherd Financial Partners's 13F filing for Q1 2026, filed 11 May 2026.